By Michael Erman Oct 7 (Reuters) – The pharmaceutical industry's top lobby group on Wednesday sued to invalidate the Trump administration's efforts to benchmark US drug prices to lower costs overseas
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
MANUS RAISES MORE THAN $500 MLN AFTER UNWINDING META DEAL – THE INFORMATION
MANUS RAISES MORE THAN $500 MLN AFTER UNWINDING META DEAL - THE INFORMATION (The article…
Singapore Grand Prix entertainment may be curbed if haze worsens, FIA says
By Xinghui Kok SINGAPORE, Oct 8 (Reuters) - There might be "some restrictions" on outdoor…
Bezos says Blue Origin likely to pursue IPO in coming years
Oct 7 (Reuters) - Blue Origin is likely to pursue an initial public offering in…
